Mutares Walks a Tightrope Between Debt Reduction and Deal-Making

The Munich-based holding company has a lot of plates spinning. In the space of just a few weeks, Mutares has launched a bond buyback after tripping a covenant, sold its Polish bus operator Relobus, and is closing in on its largest-ever acquisition of SABIC’s ETP business. Yet the stock, trading at €26.35, has shed nearly 12% since the start of the year — a disconnect that underscores just how much hinges on execution.

The immediate pressure point is debt. At the end of the first quarter, Mutares carried total debt of €385 million, and a spike in leasing liabilities combined with valuation effects pushed its net debt-to-equity ratio above the threshold set in its Nordic bond terms. Bondholders granted a waiver, avoiding an acceleration, but the company is now under a self-imposed timetable: reduce that debt to between €250 million and €300 million by the end of 2026. To get there, Mutares launched a tender offer in mid-May to buy back up to €25 million of its variable-rate 2023/2027 Nordic note at 101% of face value plus accrued interest, representing as much as 10% of the outstanding €250 million issue. The broader plan calls for quarterly buybacks of at least €25 million starting in the second quarter of next year.

The money to fund those repurchases will come from exits, and the Relobus sale is Exhibit A. Mutares acquired the Polish bus operator in 2023, overhauled its bidding processes, tightened cost controls, and landed two new 10-year contracts in Warsaw for 108 buses plus a contract in Gda?sk. The turnaround caught the eye of Infracapital, the infrastructure equity arm of M&G, which bought Relobus through one of its funds. The deal checks all the boxes for Mutares: buy, improve, sell — and proves that buyers still exist for well-groomed portfolio companies even in a cautious market.

Relobus joined a busy first-quarter exit list that already included Kalzip, WIJ Special Media, inTime Group, Conexus, and Peugeot Motocycles (the latter via a management buyout). Still ahead: Magirus, which could see an IPO or a straight sale, and Dutch-based NEM Energy Group. The exit pipeline is the engine that will power both the debt reduction and the dividend promise — a minimum €2.00 per share for 2025, with a potential performance kicker if exits go well.

Should investors sell immediately? Or is it worth buying Mutares?

Operationally, the picture is improving but mixed. First-quarter group revenue rose 10% to €1.6787 billion, while adjusted EBITDA swung from a loss of €30.1 million a year ago to a positive €11.1 million. Consolidated EBITDA came in at €162.4 million, boosted by bargain purchase gains from acquisitions. However, net income on the holding level was only minus €0.9 million, weighed down by a €6 million consent fee related to the covenant waiver. Four of Mutares’s five segments posted positive adjusted EBITDA; the laggard is Goods & Services, where the retail business continues to drag.

The big test for the buy-and-build strategy will come with the planned acquisition of SABIC’s engineered thermoplastics (ETP) business, expected to close by the end of the second quarter. That deal was enabled by a capital increase completed in April. Mutares is also scouting targets in the US, where the acquisition pipeline already represents roughly €4.8 billion in revenue potential, and plans to open a second US site.

For the full year 2026, management holds firm on a holding-level net profit of between €165 million and €200 million, and revenue in the range of €7.9 billion to €9.1 billion. The longer-term ambition is to grow revenue by at least a quarter annually, hitting around €10 billion by the end of the decade, with net profit of €200 million. The announced dividend of €2.00 per share for the past fiscal year is scheduled for payment in July, with the ex-date in the same month.

Mutares at a turning point? This analysis reveals what investors need to know now.

The stock, at €26.50 after the Relobus news, remains far below its 52-week high of €36.75 but has stabilised since hitting a low in late April. The average analyst price target of roughly €47.50 implies significant upside — but only if Mutares can execute its exit pipeline at pace, keep the covenant issue behind it through disciplined buybacks, and close the SABIC deal without a hitch. Each of those tasks is manageable on its own. Juggling all of them at once is where the real challenge lies.

Ad

Mutares Stock: New Analysis - 13 May

Fresh Mutares information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Mutares analysis...

en | DE000A2NB650 | MUTARES | boerse | 69322798 |